Zobrazeno 1 - 3
of 3
pro vyhledávání: '"John F. Reitan"'
Autor:
Sanatan Shreay, Fred J. Kudrik, Patricia K. Corey-Lisle, John F. Reitan, Kayleen Fox, Arletta van Breda
Publikováno v:
Journal of Medical Economics. 16:633-638
The objective is to measure the burden of blood transfusion of Packed Red Blood Cells (PRBCs) in patients with chemotherapy-induced anemia (CIA) on the institutional outpatient transfusion center.This is a retrospective chart review (starting July 1,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d77debf3501cca5ed5b27b9b06566012
https://doi.org/10.3111/13696998.2013.778269
https://doi.org/10.3111/13696998.2013.778269
Autor:
J. Mark Stephens, John P. Caloyeras, Larry C. Emerson, Leslie A Spry, Akhtar Ashfaq, Ernest R Anderson, John F Reitan
Publikováno v:
Current medical research and opinion. 32(2)
Previous research suggests that erythropoiesis stimulating agent (ESA) administration in dialysis is a time-consuming task and switching to less frequently dosed ESAs may offer operational efficiencies. Our objective was to describe and measure the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5318720a1cded297e52ab2403c1e58b
https://pubmed.ncbi.nlm.nih.gov/26583202
https://pubmed.ncbi.nlm.nih.gov/26583202
Autor:
Ze Cong, Sanatan Shreay, Jason C. Legg, Arletta van Breda, Patricia K. Corey-Lisle, John F. Reitan
Publikováno v:
Clinical Drug Investigation
Background Erythropoiesis-stimulating agents (ESAs) are used for the management of anaemia in patients with non-myeloid malignancies where anaemia is due to the effect of concomitant myelosuppressive chemotherapy. Assessing the impact of different ES
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910002c2b71e9190afd743765d240361